SEARCH

SEARCH BY CITATION

References

  • 1
    Liu, Y.-J., IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 2005. 23: 275306.
  • 2
    Gilliet, M., Cao, W. and Liu, Y.-J., Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 2008. 8: 594606.
  • 3
    Ganguly, D., Chamilos, G., Lande, R., Gregorio, J., Meller, S., Facchinetti, V., Homey, B. et al., Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J. Exp. Med. 2009. 206: 19831994.
  • 4
    Weisberg, E., Manley, P. W., Cowan-Jacob, S. W., Hochhaus, A. and Griffin, J. D., Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia. Nat. Rev. Cancer 2007. 7: 345356.
  • 5
    Lombardo, L. J., Lee, F. Y., Chen, P., Norris, D., Barrish, J. C., Behnia, K., Castaneda, S. et al., Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays. J. Med. Chem. 2004. 47: 66586661.
  • 6
    Schade, A. E., Schieven, G. L., Townsend, R., Jankowska, A. M., Susulic, V., Zhang, R., Szpurka, H. and Maciejewski, J. P., Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation. Blood 2008. 111: 13661377.
  • 7
    Fei, F., Yu, Y., Schmitt, A., Rojewski, M. T., Chen, B., Greiner, J., Götz, M. et al., Dasatinib exerts an immunosuppressive effect on CD8+ T cells specific for viral and leukemia antigens. Exp. Hematol. 2008. 36: 12971308.
  • 8
    Blake, S. J., Bruce Lyons, A., Fraser, C. K., Hayball, J. D. and Hughes, T. P., Dasatinib suppresses in vitro natural killer cell cytotoxicity. Blood 2008. 111: 44154416.
  • 9
    Salih, J., Hilpert, J., Placke, T., Grünebach, F., Steinle, A., Salih, H. R. and Krusch, M., The BCR/ABL-inhibitors imatinib, nilotinib and dasatinib differentially affect NK cell reactivity. Int. J. Cancer 2010. 127: 21192128.
  • 10
    Manley, P. W., Stiefl, N., Cowan-Jacob, S. W., Kaufman, S., Mestan, J., Wartmann, M., Wiesmann, M. et al., Structural resemblances and comparisons of the relative pharmacological properties of imatinib and nilotinib. Bioorg. Med. Chem. 2010. 18: 69776986.
  • 11
    Honda, K., Ohba, Y., Yanai, H., Negishi, H., Mizutani, T., Takaoka, A., Taya, C. and Taniguchi, T., Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 2005. 434: 10351040.
  • 12
    Guiducci, C., Ott, G., Chan, J. H., Damon, E., Calacsan, C., Matray, T., Lee, K.-D. et al., Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation. J. Exp. Med. 2006. 203: 19992008.
  • 13
    Krieg, A. M., CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 2002. 20: 709760.
  • 14
    Kerkmann, M., Costa, L. T., Richter, C., Rothenfusser, S., Battiany, J., Hornung, V., Johnson, J. et al., Spontaneous formation of nucleic acid-based nanoparticles is responsible for high interferon-{alpha} induction by CpG-A in plasmacytoid dendritic cells. J. Biol. Chem. 2005. 280: 80868093.
  • 15
    Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.-H., Homey, B., Cao, W. et al., Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007. 449: 564569.
  • 16
    Krug, A., Rothenfusser, S., Hornung, V., Jahrsdorfer, B., Blackwell, S., Ballas, Z. K., Endres, S. et al., Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur. J. Immunol. 2001. 31: 21542163.
  • 17
    Hanke, J. H., Gardner, J. P., Dow, R. L., Changelian, P. S., Brissette, W. H., Weringer, E. J., Pollok, B. A. and Connelly, P. A., Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. J. Biol. Chem. 1996. 271: 695701.
  • 18
    Blake, R. A., Broome, M. A., Liu, X., Wu, J., Gishizky, M., Sun, L. and Courtneidge, S. A., SU6656, a selective Src family kinase inhibitor, used to probe growth factor signaling. Mol. Cell. Biol. 2000. 20: 90189027.
  • 19
    Latz, E., Schoenemeyer, A., Visintin, A., Fitzgerald, K. A., Monks, B. G., Knetter, C. F., Lien, E. et al., TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol. 2004. 5: 190198.
  • 20
    Hirai, M., Kadowaki, N., Kitawaki, T., Fujita, H., Takaori-Kondo, A., Fukui, R., Miyake, K. et al., Bortezomib suppresses function and survival of plasmacytoid dendritic cells by targeting intracellular trafficking of Toll-like receptors and endoplasmic reticulum homeostasis. Blood 2011. 117: 500509.
  • 21
    Manders, E. M. M., Verbeek, F. J. and Aten, J. A., Measurement of colocalization of objects in dual-color confocal images. J. Microsc. 1993. 169: 375382.
  • 22
    Dunn, K. W., Kamocka, M. M. and McDonald, J. H., A practical guide to evaluating colocalization in biological microscopy. Am. J. Physiol. Cell Physiol. 2011. 300: C723-C742.
  • 23
    Costes, S. V., Daelemans, D., Cho, E. H., Dobbin, Z., Pavlakis, G. and Lockett, S., Automatic and quantitative measurement of protein-protein colocalization in live cells. Biophys. J. 2004. 86: 39934003.
  • 24
    Kaisho, T. and Tanaka, T., Turning NF-[kappa]B and IRFs on and off in DC. Trends Immunol. 2008. 29: 329336.
  • 25
    Park, B., Brinkmann, M. M., Spooner, E., Lee, C. C., Kim, Y.-M. and Ploegh, H. L., Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9. Nat. Immunol. 2008. 9: 14071414.
  • 26
    Maeda, T., Murata, K., Fukushima, T., Sugahara, K., Tsuruda, K., Anami, M., Onimaru, Y. et al., A novel plasmacytoid dendritic cell line, CAL-1, established from a patient with blastic natural killer cell lymphoma. Int. J. Hematol. 2005. 81: 148154.
  • 27
    Sanjuan, M. A., Rao, N., Lai, K.-T. A., Gu, Y., Sun, S., Fuchs, A., Fung-Leung, W.-P. et al., CpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretion. J. Cell Biol. 2006. 172: 10571068.
  • 28
    Liberali, P., Rämö, P. and Pelkmans, L., Protein kinases: starting a molecular systems view of endocytosis. Annu. Rev. Cell Dev. Biol. 2008. 24: 501523.
  • 29
    Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Boesche, M., Hobson, S., Mathieson, T. et al., Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Nat. Biotechnol. 2007. 25: 10351044.
  • 30
    Rix, U., Hantschel, O., Durnberger, G., Remsing Rix, L. L., Planyavsky, M., Fernbach, N. V., Kaupe, I. et al., Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets. Blood 2007. 110: 40554063.
  • 31
    Karaman, M. W., Herrgard, S., Treiber, D. K., Gallant, P., Atteridge, C. E., Campbell, B. T., Chan, K. W. et al., A quantitative analysis of kinase inhibitor selectivity. Nat. Biotechnol. 2008. 26: 127132.
  • 32
    Li, J., Rix, U., Fang, B., Bai, Y., Edwards, A., Colinge, J., Bennett, K. L. et al., A chemical and phosphoproteomic characterization of dasatinib action in lung cancer. Nat. Chem. Biol. 2010. 6: 291299.
  • 33
    Sasai, M., Linehan, M. M. and Iwasaki, A., Bifurcation of Toll-Like receptor 9 signaling by adaptor protein 3. Science 2010. 329: 15301534.
  • 34
    Blasius, A. L., Arnold, C. N., Georgel, P., Rutschmann, S., Xia, Y., Lin, P., Ross, C. et al., Slc15a4, AP-3, and Hermansky-Pudlak syndrome proteins are required for Toll-like receptor signaling in plasmacytoid dendritic cells. Proc. Natl. Acad. Sci. USA 2010. 107: 1997319978.
  • 35
    Lee, J., Tattoli, I., Wojtal, K. A., Vavricka, S. R., Philpott, D. J. and Girardin, S. E., pH-dependent internalization of muramyl peptides from early endosomes enables Nod1 and Nod2 signaling. J. Biol. Chem. 2009. 284: 2381823829.
  • 36
    Di Pietro, S. M., Falcón-Pérez, J. M., Tenza, D., Setty, S. R. G., Marks, M. S., Raposo, G. and Dell'Angelica, E. C., BLOC-1 interacts with BLOC-2 and the AP-3 complex to facilitate protein trafficking on endosomes. Mol. Biol. Cell 2006. 17: 40274038.
  • 37
    Setty, S. R. G., Tenza, D., Truschel, S. T., Chou, E., Sviderskaya, E. V., Theos, A. C., Lamoreux, M. L. et al., BLOC-1 is required for cargo-specific sorting from vacuolar early endosomes toward lysosome-related organelles. Mol. Biol. Cell 2007. 18: 768780.
  • 38
    Kawamura, K., Kadowaki, N., Kitawaki, T. and Uchiyama, T., Virus-stimulated plasmacytoid dendritic cells induce CD4 +cytotoxic regulatory T cells. Blood 2006. 107: 10311038.
  • 39
    Hartmann, G., Weeratna, R. D., Ballas, Z. K., Payette, P., Blackwell, S., Suparto, I., Rasmussen, W. L. et al., Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J. Immunol. 2000. 164: 16171624.